Yan Xiu's profile photo

Yan Xiu

Featured in: Favicon nature.com Favicon wiley.com Favicon acs.org Favicon jamanetwork.com Favicon cell.com Favicon onlinelibrary.wiley.com Favicon pubs.acs.org

Articles

  • Recombinant Human Thyrotropin Plus Radioactive Iodine Among Patients With Thyroid Cancer

    Nov 7, 2024 | jamanetwork.com | Hui Tan |Yan Xiu |Xingmin Han |Yushen Gu

    Key PointsQuestion  How does the efficacy and safety profile of recombinant human thyrotropin (SNA001) compare with those of thyroid hormone withdrawal (THW) as a stimulation method for radioactive iodine (131I or RAI) therapy in patients with intermediate-risk differentiated thyroid cancer (DTC)? Findings  In this randomized clinical trial of 307 patients with predominantly intermediate-risk DTC, SNA001 demonstrated noninferiority to THW in successful RAI therapy.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →